PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: "Pfizer Settles With DOJ for $35 Million in Genotropin Scandal; Who Knew?"

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.


Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) Please read the terms of use agreement and privacy policy for this blog carefully.

"Pfizer Settles With DOJ for $35 Million in Genotropin Scandal; Who Knew?"

From BrandweekNRX

Pfizer Settles With DOJ for $35 Million in Genotropin Scandal; Who Knew?
By Jim Edwards

As expected, Pfizer has settled with the DOJ over the off-label marketing of Genotropin. The price is $34.7 million; probably an insignificant sum in terms of reporting to the SEC. Read the news here.

If you want the full background on this sordid saga, read Brandweek's lengthy account of it here.
Without wishing to be a blowhard about it, I'd like to note that what Pfizer is pleading guilty to today--including the alleged kickback scheme that Peter Rost said existed with Express Scripts--is pretty much exactly what I reported a year ago.

Rost, in fact, is already doing his victory dance.

Let us not forget all the other important people in the drug biz who are loosely, so very loosely, connected to this scandal:

First, there's Schering-Plough CEO Fred Hassan, the former chief of Pharmacia, who asked his lieutenants to "follow up" when Pharmacia was first approached by an anti-aging quack to get into the off-label human growth hormone business. Pharmacia ended up signing a contract with that guy and he bought plenty of HGH.

Then there's Jeff Kindler, the CEO of Pfizer, who as counsel to Pfizer was warned by Rost that Pharmacia was engaged in off-label marketing prior to PFE's acquisition of the company. Pfizer bought the company anyway!

And there's Marie Caroline Sainpy, Pfizer's SVP US Pharmaceuticals marketing and worldwide commercial development, who fired Rost after he started complaining about Genotropin's marketing.

Don't forget Margriet Gabriel-Regis, an svp at Schering-Plough in the specialty care customer group--while at Pharmacia she wrote a memo telling Pharmacia staff that off-label marketing was wrong but that Pharmacia was going to conduct "a series of clinical studies" to "explore clinical endpoints in the elderly" anyway!

What about Steve Mahinka, the Morgan Lewis & Bockius lawyer who wrote a hilarious memo in February 2000 advising Pharmacia it was OK to get into the anti-aging business even though it was off-label? Why so hilarious? Because it neglected to mention the criminal statute that controls HGH marketing. D'oh!

Lastly, there's Rick Collier, the former general counsel at Pharmacia, who's now general counsel at Elan Pharma, who bought that advice from Mahinka.

The DOJ says thanks for the check.



Anonymous Rosethejet said...


That's chump change to the pharma companies. I mean like an hours worth of work or something.

They should have hit them with one and a half billion.

THAT would have gotten their attention. But right now it's just cost effectiveness vs profit.

Profit won.

What's with the moderation thing? Problems?


Post a Comment

Links to this post:

Create a Link

<< Home